Miniatura

Fitxers

645394.pdf (1.51 MB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2014-11-03

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/60865

Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1002/ijc.29261

Resum

Ovarian cancer (OC) is caused by genetic aberrations in networks that control growth and survival. Importantly, aberrant cancer metabolism interacts with oncogenic signaling providing additional drug targets. Tumors overexpress the lipogenic enzyme fatty acid synthase (FASN) and are inhibited by FASN blockers, whereas normal cells are FASN-negative and FASN-inhibitor-resistant. Here, we demonstrate that this holds true when ovarian/oviductal cells reside in their autochthonous tissues, whereas in culture they express FASN and are FASN-inhibitor-sensitive. Upon subculture, nonmalignant cells cease growth, express senescence-associated β-galactosidase, lose FASN and become FASN-inhibitor-resistant. Immortalized ovarian/oviductal epithelial cell lines although resisting senescence reveal distinct growth activities, which correlate with FASN levels and FASN drug sensitivities. Accordingly, ectopic FASN stimulates growth in these cells. Moreover, FASN levels and lipogenic activities affect cellular lipid composition as demonstrated by thin-layer chromatography. Correlation between proliferation and FASN levels was finally evaluated in cancer cells such as HOC-7, which contain subclones with variable differentiation/senescence and corresponding FASN expression/FASN drug sensitivity. Interestingly, senescent phenotypes can be induced in parental HOC-7 by differentiating agents. In OC cells, FASN drugs induce cell cycle blockade in S and/or G2/M and stimulate apoptosis, whereas in normal cells they only cause cell cycle deceleration without apoptosis. Thus, normal cells, although growth-inhibited, may survive and recover from FASN blockade, whereas malignant cells get extinguished. FASN expression and FASN drug sensitivity are directly linked to cell growth and correlate with transformation/differentiation/senescence only indirectly. FASN is therefore a metabolic marker of cell proliferation rather than a marker of malignancy and is a useful target for future drug development.

Matèries

Trompes de Fal·lopi, Cèl·lules epitelials, Càncer d'ovari, Vellesa, Àcids grassos

Matèries (anglès)

Fallopian tubes, Epithelial cells, Ovarian cancer, Old age, Fatty acids

Citació

Col·leccions

Articles publicats en revistes (Química Inorgànica i Orgànica)

Citació

VEIGEL, Daniel, WAGNER, Renate, STÜBIGER, Gerald, WUCZKOWSKI, Michael, FILIPITS, Martin, HORVAT, Reinhard, BENHAMÚ, Bellinda, LÓPEZ-RODRÍGUEZ, María luz, LEISSER, Asha, VALENT, Peter, GRUSCH, Michael, HEGARDT, Fausto, GARCÍA GÓMEZ, Jordi, SERRA I CUCURULL, Dolors, AUERSPERG, Nelly, COLOMER, Ramón, GRUNT, Thomas. Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells. _International Journal of Cancer_. vol. 136 num. 9. Vol.  2015, núm. 2078-2090. [consulta: 31 de gener de 2026]. ISSN: 0020-7136. [Disponible a: https://hdl.handle.net/2445/60865]

Exportar metadades

JSON - METS

Compartir registre